InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Location
Vancouver, British Columbia, Canada
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 506% %
Quick Ratio 54% %
Debt-to-equity 22% %
Return On Equity -86% % -31%
Return On Assets -70% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,384,186 shares -82%
Common Stock, Shares, Outstanding 2,604,186 shares 290%
Entity Public Float $3,316,582 USD 41%
Common Stock, Value, Issued $91,806,396 USD 9%
Weighted Average Number of Shares Outstanding, Basic 3,954,549 shares 538%
Weighted Average Number of Shares Outstanding, Diluted 3,954,549 shares 538%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $4,798,116 USD -3.3%
Cost of Revenue $3,181,784 USD -6.1%
Research and Development Expense $2,735,387 USD 4.2%
General and Administrative Expense $6,596,876 USD 10%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8,211,164 USD -21%
Net Income (Loss) Attributable to Parent $8,211,164 USD -20%
Earnings Per Share, Basic -6 USD/shares 20%
Earnings Per Share, Diluted -6 USD/shares 20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,331,077 USD 67%
Cash, Cash Equivalents, and Short-term Investments $9,400,000 USD 68%
Accounts Receivable, after Allowance for Credit Loss, Current $343,469 USD 21%
Inventory, Net $890,807 USD -27%
Assets, Current $10,799,967 USD 48%
Property, Plant and Equipment, Net $881,549 USD -34%
Intangible Assets, Net (Excluding Goodwill) $1,579,569 USD -9.3%
Other Assets, Noncurrent $100,000 USD 0%
Assets $13,361,085 USD 28%
Accounts Payable, Current $2,000 USD
Employee-related Liabilities, Current $274,250 USD
Accrued Liabilities, Current $85,521 USD
Liabilities, Current $1,554,984 USD 8.3%
Operating Lease, Liability, Noncurrent $215,478 USD -66%
Liabilities $1,770,462 USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $128,569 USD 0%
Retained Earnings (Accumulated Deficit) $118,964,791 USD -7.4%
Stockholders' Equity Attributable to Parent $11,590,623 USD 38%
Liabilities and Equity $13,361,085 USD 28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,607,616 USD 12%
Net Cash Provided by (Used in) Financing Activities $137,178 USD -116%
Common Stock, Shares, Issued 2,604,186 shares 290%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9,331,077 USD 67%
Deferred Tax Assets, Valuation Allowance $26,821,820 USD 18%
Deferred Tax Assets, Gross $26,821,820 USD 18%
Operating Lease, Liability $640,243 USD -39%
Depreciation $50,204 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid $668,267 USD -41%
Property, Plant and Equipment, Gross $2,330,559 USD -11%
Operating Lease, Liability, Current $424,765 USD 0.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $219,261 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $449,006 USD -0.92%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28,024 USD -67%
Lessee, Operating Lease, Liability, to be Paid, Year Three $219,261 USD -80%
Deferred Tax Assets, Operating Loss Carryforwards $5,400,000 USD -28%
Amortization of Intangible Assets $162,636 USD -5.4%
Depreciation, Depletion and Amortization $53,202 USD -2.5%
Share-based Payment Arrangement, Expense $20,205 USD -86%